PT1165051E - Processo para a preparacao de uma forma de dosagem oral biodisponivel de cefuroxima axetil - Google Patents
Processo para a preparacao de uma forma de dosagem oral biodisponivel de cefuroxima axetilInfo
- Publication number
- PT1165051E PT1165051E PT00909562T PT00909562T PT1165051E PT 1165051 E PT1165051 E PT 1165051E PT 00909562 T PT00909562 T PT 00909562T PT 00909562 T PT00909562 T PT 00909562T PT 1165051 E PT1165051 E PT 1165051E
- Authority
- PT
- Portugal
- Prior art keywords
- dosage form
- oral dosage
- axetil
- cefuroxima
- biodisponable
- Prior art date
Links
- 239000006186 oral dosage form Substances 0.000 title abstract 2
- 229950003588 axetil Drugs 0.000 title 1
- JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 title 1
- KEJCWVGMRLCZQQ-YJBYXUATSA-N Cefuroxime axetil Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(=O)OC(C)OC(C)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 KEJCWVGMRLCZQQ-YJBYXUATSA-N 0.000 abstract 2
- 229960002620 cefuroxime axetil Drugs 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN453DE1999 IN190831B (pt) | 1999-03-19 | 1999-03-19 | |
| US09/366,986 US6346530B1 (en) | 1999-03-19 | 1999-08-04 | Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1165051E true PT1165051E (pt) | 2003-11-28 |
Family
ID=26324612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00909562T PT1165051E (pt) | 1999-03-19 | 2000-03-17 | Processo para a preparacao de uma forma de dosagem oral biodisponivel de cefuroxima axetil |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6323193B1 (pt) |
| EP (1) | EP1165051B1 (pt) |
| AT (1) | ATE244560T1 (pt) |
| AU (1) | AU3184300A (pt) |
| BR (1) | BR0009177A (pt) |
| CA (1) | CA2366617A1 (pt) |
| ES (1) | ES2202069T3 (pt) |
| HK (1) | HK1043540B (pt) |
| PT (1) | PT1165051E (pt) |
| WO (1) | WO2000056286A1 (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003000238A1 (en) * | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drug |
| WO2005002540A2 (en) * | 2003-07-01 | 2005-01-13 | Ranbaxy Laboratories Limited | Dry powder pharmaceutical suspension compositions of cefuroxime axetil |
| GB0400971D0 (en) * | 2004-01-16 | 2004-02-18 | Sandoz Ag | Pharmaceutical compositions |
| WO2005099666A2 (en) * | 2004-04-01 | 2005-10-27 | Teva Pharmaceutical Industries Ltd. | Delayed release formulations of 6-mercaptopurine |
| US8188067B2 (en) | 2004-04-01 | 2012-05-29 | Teva Pharmaceutical Industries Ltd. | Formulations of 6-mercaptopurine |
| DE102005019458A1 (de) * | 2005-04-25 | 2006-10-26 | Grünenthal GmbH | Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil |
| US8900637B2 (en) | 2005-12-02 | 2014-12-02 | Lupin Limited | Stable taste masked formulations of cephalosporins |
| EP2110130A1 (en) * | 2008-04-18 | 2009-10-21 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical use of 6-mercaptopurine |
| US20100056825A1 (en) * | 2008-08-28 | 2010-03-04 | Telik, Inc. | Formulations of canfosfamide and their preparation |
| US8324426B2 (en) * | 2008-08-28 | 2012-12-04 | Telik, Inc. | Formulations of canfosfamide and their preparation |
| EP2566458B1 (en) * | 2010-05-04 | 2015-08-05 | Mahmut Bilgic | Pharmaceutical formulations compising cefuroxime axetil |
| WO2013100880A1 (en) * | 2011-12-27 | 2013-07-04 | Mahmut Bilgic | Formulations comprising cefuroxime |
| US8313774B1 (en) * | 2012-06-26 | 2012-11-20 | Magnifica Inc. | Oral solid composition |
| EP3362053A4 (en) | 2015-10-16 | 2019-04-17 | Hadasit Medical Research Services and Development Ltd. | TREATMENT OF NON-ALCOHOLIC FATTYLENE OR NON-ALCOHOLIC STEATOHEPATITIS WITH 6-MERCAPTOPURIN WITH DELAYED RELEASE |
| KR20200109291A (ko) * | 2017-08-18 | 2020-09-22 | 애브비 인코포레이티드 | 자궁내막증, 자궁섬유증, 다낭난소증후군 또는 샘근육증을 치료하기 위한 약제학적 제형 |
| WO2019036713A1 (en) | 2017-08-18 | 2019-02-21 | Abbvie Inc. | SOLID PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF ENDOMETRIOSIS, UTERINE FIBROIDS, POLYKYSTIC OVARY SYNDROME AND ADENOMYOSIS |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1094545A (en) | 1976-02-16 | 1981-01-27 | Michael Gregson | Cephalosporin antibiotics |
| YU44680B (en) * | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
| KR100187959B1 (ko) * | 1997-03-31 | 1999-06-01 | 윤재승 | 저융점 무정형 세푸록심 악세틸의 제조방법 |
| IN186539B (pt) * | 1997-09-29 | 2001-09-29 | Ranbaxy Lab Ltd |
-
2000
- 2000-03-17 AT AT00909562T patent/ATE244560T1/de not_active IP Right Cessation
- 2000-03-17 HK HK02104843.9A patent/HK1043540B/en not_active IP Right Cessation
- 2000-03-17 BR BR0009177-4A patent/BR0009177A/pt not_active IP Right Cessation
- 2000-03-17 ES ES00909562T patent/ES2202069T3/es not_active Expired - Lifetime
- 2000-03-17 CA CA002366617A patent/CA2366617A1/en not_active Abandoned
- 2000-03-17 EP EP00909562A patent/EP1165051B1/en not_active Expired - Lifetime
- 2000-03-17 PT PT00909562T patent/PT1165051E/pt unknown
- 2000-03-17 WO PCT/IB2000/000292 patent/WO2000056286A1/en not_active Ceased
- 2000-03-17 AU AU31843/00A patent/AU3184300A/en not_active Abandoned
- 2000-08-21 US US09/642,402 patent/US6323193B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2366617A1 (en) | 2000-09-28 |
| US6323193B1 (en) | 2001-11-27 |
| ATE244560T1 (de) | 2003-07-15 |
| BR0009177A (pt) | 2002-01-22 |
| WO2000056286A1 (en) | 2000-09-28 |
| HK1043540A1 (en) | 2002-09-20 |
| HK1043540B (en) | 2003-12-24 |
| AU3184300A (en) | 2000-10-09 |
| ES2202069T3 (es) | 2004-04-01 |
| EP1165051B1 (en) | 2003-07-09 |
| EP1165051A1 (en) | 2002-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1165051E (pt) | Processo para a preparacao de uma forma de dosagem oral biodisponivel de cefuroxima axetil | |
| GB0010669D0 (en) | Compositions for treatment of disorders of the oesophagus | |
| AU5649601A (en) | Synthetic process for the manufacture of an ecteinaschidin compound | |
| CA2379445A1 (en) | Lactams substituted by cyclic succinates as inhibitors of a.beta. protein production | |
| NO20071547L (no) | Nye krystallinske og amorfe former av en triazolo(4,5-D)pyrimidinforbindelse | |
| IL156280A0 (en) | Crystalline forms of atorvastatin | |
| BR9804857A (pt) | Processo para a produ-Æo fermentativa de ceffalosporinas desaciladas | |
| DE69609576D1 (de) | Bioverfügbare kristalline Form des Cefuroxim-Axetils | |
| HUP0204026A3 (en) | Pharmaceutical composition containing cefuroxime axetil | |
| TW200420541A (en) | Crystalline forms | |
| MXPA02001813A (es) | Hidroxialcanoilaminolactamas y estructuras relacionas como inhibidores de la produccion de la proteina abeta. | |
| AU2001284385A1 (en) | An improved process for the preparation of amorphous atorvastatin calcium salt (2:1) | |
| AU2002307805A1 (en) | Process for the preparation of cefdinir | |
| NO20024321D0 (no) | Fremgangsmåte for fremstilling av krystallinsk form I av kabergolin | |
| SG99351A1 (en) | Process for the manufacture of a crystalline solid | |
| DE60015508T2 (de) | C-16 ungesätigte fp-selektive prostaglandin analoge | |
| AU2002245005A1 (en) | Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor | |
| FR2796641B1 (fr) | Nouveau procede de preparation de composes benzoperhydroisoindole | |
| PT831820E (pt) | Composicao farmaceutica oral de compostos de piperidinoalcanol em forma de solucao | |
| NO20006073L (no) | Fremgangsmåte for fremstilling av krystallinske salter av amoxycillin | |
| AU2003212351A8 (en) | A process for the preparation of cephalosporan acid derivatives from cephalosporin c | |
| HUP0300648A3 (en) | Synthetic process for the manufacture of an ecteinaschidin compound | |
| AU2002356423A1 (en) | Process for the preparation of amorphous atorvastatin calcium | |
| EP1142898A4 (en) | METHOD FOR PRODUCING PHOSPHONITE COMPOUNDS | |
| IL162770A0 (en) | Process for the preparation methylsteroids of 7 |